Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-06-14
2005-06-14
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S185000, C514S063000, C514S189000, C514S740000, C540S121000, C540S145000
Reexamination Certificate
active
06906050
ABSTRACT:
Substituted porphyrin and azaporphyrin deviations with various substitutents in the 12- and 17-positions of the porphyrin skeleton as pharmaceutical agents for use in photodynamic therapy, MRI diagnosis, and radiodiagnostics.
REFERENCES:
patent: 4647447 (1987-03-01), Gries et al.
patent: 4882234 (1989-11-01), Lai et al.
patent: 4885363 (1989-12-01), Tweedle et al.
patent: 4996312 (1991-02-01), Sakata et al.
patent: 5053503 (1991-10-01), Dean et al.
patent: 5275801 (1994-01-01), Niedballa et al.
patent: 5277895 (1994-01-01), Platzek et al.
patent: 5364614 (1994-11-01), Platzek et al.
patent: 5633275 (1997-05-01), Mori et al.
patent: 5654423 (1997-08-01), Kahl et al.
patent: 5675001 (1997-10-01), Hoffman et al.
patent: 5676923 (1997-10-01), Platzek et al.
patent: 5703230 (1997-12-01), Boyle et al.
patent: 5705622 (1998-01-01), McCapra
patent: 5730956 (1998-03-01), Platzek et al.
patent: 5849259 (1998-12-01), Hilger et al.
patent: 6136841 (2000-10-01), Platzek et al.
patent: 6251367 (2001-06-01), Platzek et al.
patent: 1341176 (2001-01-01), None
patent: 0 220 686 (1986-10-01), None
patent: 0 232 751 (1991-09-01), None
patent: 0 811 626 (1997-12-01), None
patent: WO 92/06097 (1992-04-01), None
patent: WO 96/01655 (1996-01-01), None
patent: WO 96/02669 (1996-02-01), None
patent: WO 97/20846 (1997-06-01), None
patent: WO 99/62512 (1999-12-01), None
patent: WO 00/05235 (2000-02-01), None
patent: 937194 (1993-09-01), None
Chemical Abstract DN 103:188202, also cited as Seria Flzyka, 255-8(1985).
Chemical Abstract DN 87:53240, also cited as Justus Lieb. Annal. 3, 339-59(1977).
Chemical Abstract DN 81:113159, also cited as Zhurnal Prikladnoli Spek. 21/1,73-81(1974).
Chemical Abstract DN 73:30379, also cited as Izvestiya Akademil Nauk SSSR, 34/3,620-4(1970).
PubMed Abstract 8040757, also cited as J. Photochem. Photobiol B. 23/2-3,239-43(1994).
PubMed Abstract 12114873, also cited as Q. J. Nucl. Med. 46/2,105-12(2002).
PubMed Abstract 15073860, also cited as Cancer, 100/8, 1705-11(2004).
PubMed Abstract 12844192, also cited as Natl. Toxicol. Program. Tech Rep. Ser. Jan. 6, 1-203(1997).
Dzilinski et al Chemical Abstract DN 103:188202 also cited as Seria Fizyka, 255-8(1985).
Furhop et al Chemical Abstract DN 87:53240 also cited as Justug Liebigs Ann. der Chem.3,339-59(1977).
Masshenkov et al, Chemical Abstract DN 81:113159, also cited as Zhurnal Prik. Spektr. 21/1,73-81(1974).
Gurinovitch et al, Chemical Abstract DN 73:30379, also cited as Izuestiya Akademii Nauk SSSR 34/2,620-4(1970).
David Kessel, et al.,Tumor-localizing Components of the Porphyrin Preparation Hematoporphyrin, 43 Cancer Research 1994-1999 (1983).
David R. Sanderson, et al.,Hematoporphyrin As A Diagnostic Tool, 30 Cancer 1368-1372 (1972).
Frederick R. Longo, et al.,Kinetic and Mechanistic Studies of Metalloporphyrin Formation, The Porphyrins, V Academic Press 459 (1980).
H. Fischer et al.,Z. Physiol. Chem., 201-219 (1936).
James Winkelmann, et al.,The Concentration in Tumor and Other Tissues of Parenterally Administered Tritium- and14C-labeld Tetraphenyloporphinesulfonate1, 27 Cancer Research 2060-2064 (1967).
Kark M. Kadish, et al.,Synthesis and Organic Chemistry, The Porphyrin Handbook, Table of Contents, I Academic Press, Chapters 1-3 (2000).
Kevin M. Smith,Porphyrins and Metalloporphyrins, Elsevier (1975).
N.J. Patronas, et al.,Metalloporphyrin Contrast Agents for Magnetic Resonance Imaging of Human Tumors in Mice, 70 Cancer Treatment Reports 391-395 (1986).
Nagao Kobayashi,meso-Azaporphyrins and Their Analogues, The Porphyrin Handbook, 2 Academic Press 301-360 (2000).
P. Hambright, et al.,The Distribution of Various Water Soluble Radioactive Metalloporphyrins in Tumor Bearing Mice, 5 Bioinorganic Chemistry 87-92 (1975).
Richard L. Lipson, et. al.,Hematoporphyrin Derivative For Detection And Management of Cancer, 20 Cancer 2250-2257 (1967).
S. Nakajima, et al.,Tumor Imaging with[111In]Mono-DTPA ethyleneglycol-Ga-Deuteroporphyrin, 46 Photochemistry and Photobiology 783-788 (1987).
Saburo Neya, et al.,Remarkable Functional Aspects of Myoglobin Induced by Diazaheme Prosthetic Group, 121 The Journal of Biochemistry 654-660 (1997).
Theodora W. Greene, et al.,Protective Groups in Organic Synthesis, Table of Contents (1991).
Miravant Pharmaceuticals, Inc.
Patel Sudhaker B.
Raymond Richard L.
LandOfFree
Substituted porphyrin and azaporphyrin derivatives and their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted porphyrin and azaporphyrin derivatives and their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted porphyrin and azaporphyrin derivatives and their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3521825